Benitec Biopharma Inc. (BNTC) Description, Stock price, News & Info.

#ThinkSabio Latest News

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference